// App-Quantinova.ai

WP75 : Dual Antiplatelet Therapy in Addition to Post-Operative Heparin and Dextran Reduces Clinically Symptomatic Thromboembolic Events During Elective Aneurysm Coiling

Researchers

Presenter

  • Matthew Davis

Principal Investigators

  • Aditya S Pandey

  • William Stetler

  • Neeraj Chaudhary

  • Joseph Gemmete

  • B. Gregory Thompson

Medical Centers

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Venous thrombosis

  • Diabetes

  • Obesity

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Dextran 40

  • Aspirin

  • Albyl-E

  • Dex-HEMA

  • Heparin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim